Repeated Famotidine Administration Results in a Diminished Effect on Intragastric pH in Dogs
Open Access
- 1 December 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 31 (1) , 117-123
Abstract
Background Famotidine is an acid suppressant commonly administered to dogs. Prolonged famotidine use in people results in decreased efficacy, but the effect in dogs is unknown. Hypothesis/Objectives To compare the effect of repeated oral administration of famotidine or placebo on intragastric pH and serum gastrin in dogs. We hypothesized that famotidine would have a diminished effect on intragastric pH on day 13 compared to day 1. Animals Six healthy adult colony Beagles. Methods Randomized, 2‐factor repeated‐measures crossover design. All dogs received oral placebo or 1.0 mg/kg famotidine q12h for 14 consecutive days. Intragastric pH monitoring was used to continuously record intragastric pH on treatment days 1–2 and 12–13. Mean pH as well as mean percentage time (MPT) that intragastric pH was ≥3 or ≥4 were compared between and within groups by analysis of variance. Serum gastrin was measured on days 0, 3, and 12 for each treatment. Results Continued administration of famotidine resulted in a significant decrease in mean pH, MPT ≥3, and MPT ≥4 (P < .0001) on day 12 and 13. This resulted in a mean decrease in pH by 1.63 on days 12 and 13 compared to days 1 and 2. Furthermore, a mean decrease of MPT ≥3 and MPT ≥4 by 33 and 45% was observed for the same time period, respectively. Conclusions and Clinical Importance Continued administration of famotidine results in a diminished effect on intragastric pH in dogs. Caution is advised when recommending long‐term, daily oral administration of famotidine to dogs.Keywords
Funding Information
- University of Tennessee Fund for Companion Animal Research
This publication has 24 references indexed in Scilit:
- Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysisGut, 2013
- Reported Side Effects and Complications of Long-term Proton Pump Inhibitor Use: Dissecting the EvidenceClinical Gastroenterology and Hepatology, 2013
- Normal Dogs Treated with Famotidine for 14 days Have Only Transient Increases in Serum Gastrin ConcentrationsJournal of Veterinary Internal Medicine, 2011
- Efficacy of Oral Famotidine and 2 Omeprazole Formulations for the Control of Intragastric pH in DogsJournal of Veterinary Internal Medicine, 2010
- Pancreatic response in healthy dogs fed diets of various fat compositionsAmerican Journal of Veterinary Research, 2009
- Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatmentAlimentary Pharmacology & Therapeutics, 2006
- Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infectionJournal of Gastroenterology and Hepatology, 2003
- Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physicianBest Practice & Research Clinical Gastroenterology, 2001
- Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux DiseaseDigestion, 1992
- Regulation of Receptors on Parietal Cells on Acid SecretionScandinavian Journal of Gastroenterology, 1988